Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Epigenetics and Pathogenesis of Systemic Sclerosis; the Ins and Outs Publisher Pubmed



Aslani S1 ; Sobhani S1 ; Gharibdoost F1 ; Jamshidi A1 ; Mahmoudi M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Human Immunology Published:2018


Abstract

The pathogenesis of many diseases is influenced by environmental factors which can affect human genome and be inherited from generation to generation. Adverse environmental stimuli are recognized through the epigenetic regulatory complex, leading to gene expression alteration, which in turn culminates in disease outcomes. Three epigenetic regulatory mechanisms modulate the manifestation of a gene, namely DNA methylation, histone changes, and microRNAs. Both epigenetics and genetics have been implicated in the pathogenesis of systemic sclerosis (SSc) disease. Genetic inheritance rate of SSc is low and the concordance rate in both monozygotic (MZ) and dizygotic (DZ) twins is little, implying other possible pathways in SSc pathogenesis scenario. Here, we provide an extensive overview of the studies regarding different epigenetic events which may offer insights into the pathology of SSc. Furthermore, epigenetic-based interventions to treat SSc patients were discussed. © 2018 American Society for Histocompatibility and Immunogenetics
Other Related Docs
14. Autoimmune Diseases, Clinical Immunology (2022)
23. The Immunogenetics of Systemic Sclerosis, Advances in Experimental Medicine and Biology (2022)
40. Epigenetic-Based Cancer Therapeutics: New Potential Hdac8 Inhibitors, Journal of Biomolecular Structure and Dynamics (2022)
43. Pharmacoepigenetics of Immunological Disorders, Pharmacoepigenetics (2019)
47. Dna Hypermethylation of Gdf5 in Developmental Dysplasia of the Hip (Ddh), Molecular Genetics and Genomic Medicine (2019)